RespireRx Pharmaceuticals Inc RSPI
$0.00
Last Updated: Nov 13, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
RSPI Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, RespireRx Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
RespireRx Pharmaceuticals Inc. Stock Analysis RSPI
United States Health Care Nano Cap RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company is headquartered in Glen Rock, New Jersey and currently employs 2 full-time employees. The firm is focused on treatments that address conditions affecting millions of people, but for which there are few or poor treatment options, including epilepsy, pain, attention deficit hyperactivity disorder (ADHD), recovery from SCI, certain neurological orphan diseases and obstructive sleep apnea (OSA). The firm is developing a pipeline of new and repurposed drug products based on its patent portfolios for two drug platforms: neuromodulators, which include GABAkines and AMPAkines, proprietary chemical entities that positively modulate (positive allosteric modulators or PAMs) GABAA receptors and AMPA-type glutamate receptors, respectively, and pharmaceutical cannabinoids, which include dronabinol, a synthetic compound that acts upon the nervous system’s endogenous cannabinoid receptors.
RespireRx Pharmaceuticals Inc (RSPI) Chart
Financial Metrics & Statements of RespireRx Pharmaceuticals Inc (RSPI)
FAQ's for RespireRx Pharmaceuticals Inc (RSPI)
- As of August 2026, RespireRx Pharmaceuticals Inc RSPI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RespireRx Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in RespireRx Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of RespireRx Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of RespireRx Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of RespireRx Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for RespireRx Pharmaceuticals Inc (RSPI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
